AVEO Oncology
AVEO
#7231
Rank
โ‚น49.89 B
Marketcap
โ‚น1,435
Share price
0.00%
Change (1 day)
204.07%
Change (1 year)

Earnings for AVEO Oncology (AVEO)

Earnings in 2022 (TTM): -โ‚น2.24 Billion

According to AVEO Oncology 's latest financial reports the company's current earnings are โ‚น94.31 Million. In 2021 the company made an earning of -โ‚น5.11 Billion a decrease over its 2020 earnings that were of -โ‚น3.41 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for AVEO Oncology from 2009 to 2022

Annual earnings

Year Earnings Change
2022 (TTM) -โ‚น2.24 Billion-56.17%
2021 -โ‚น5.11 Billion49.9%
2020 -โ‚น3.41 Billion-479.04%
2019 โ‚น0.89 B-276.17%
2018 -โ‚น0.51 Billion-91.79%
2017 -โ‚น6.22 Billion142.38%
2016 -โ‚น2.57 Billion78.51%
2015 -โ‚น1.44 Billion-71.55%
2014 -โ‚น5.05 Billion-50.72%
2013 -โ‚น10.25 Billion-4.88%
2012 -โ‚น10.77 Billion-426.29%
2011 โ‚น3.29 B-159.85%
2010 -โ‚น5.52 Billion35.33%
2009 -โ‚น4.08 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Eli Lilly
LLY
โ‚น2.978 T-107,283.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
โ‚น869.44 B-31,392.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
โ‚น155.28 B-5,689.04%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
โ‚น493.41 B-17,858.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚น918.24 B-33,148.66%๐Ÿ‡บ๐Ÿ‡ธ USA
Merrimack Pharmaceuticals
MACK
-โ‚น0.22 Billion-92.22%๐Ÿ‡บ๐Ÿ‡ธ USA